Work

Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small- cell lung cancer (NSCLC) : results from cohort 6 of the phase 2 GEOMETRY mono-1 study

Year: 2020

Type: article

Source: Kölner Universitäts PublikationsServer (Universität zu Köln)

Authors: Jennifer Moriatis Wolf, Harry J.M. Groen, Wallace Akerley, P.-J. Souquet, Eckart Laack, Ji‐Youn Han, Egbert F. Smit, Aaron S. Mansfield, Edward B. Garon, Daniel S.W. Tan, Rebecca S. Heist, Maeve Waldron-Lynch, Sylvie Le Mouhaër, Ngozi Nwana, Marco Giovannini, С. В. Орлов

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3123868154

FWCI: 0.123

Cites:

Cited by: 1

Related to: 20